[go: up one dir, main page]

PL308551A1 - Application of bhpa compounds in combination with other nucleosidal inhibitors of reverse transcriptase in treating hiv infections - Google Patents

Application of bhpa compounds in combination with other nucleosidal inhibitors of reverse transcriptase in treating hiv infections

Info

Publication number
PL308551A1
PL308551A1 PL93308551A PL30855193A PL308551A1 PL 308551 A1 PL308551 A1 PL 308551A1 PL 93308551 A PL93308551 A PL 93308551A PL 30855193 A PL30855193 A PL 30855193A PL 308551 A1 PL308551 A1 PL 308551A1
Authority
PL
Poland
Prior art keywords
nucleosidal
bhpa
inhibitors
compounds
combination
Prior art date
Application number
PL93308551A
Inventor
William Gary Tarpley
Thomas Jerome Dueweke
Donald Herman M D Batts
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of PL308551A1 publication Critical patent/PL308551A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL93308551A 1992-10-28 1993-09-10 Application of bhpa compounds in combination with other nucleosidal inhibitors of reverse transcriptase in treating hiv infections PL308551A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96763992A 1992-10-28 1992-10-28
US1711993A 1993-02-12 1993-02-12

Publications (1)

Publication Number Publication Date
PL308551A1 true PL308551A1 (en) 1995-08-21

Family

ID=26689480

Family Applications (1)

Application Number Title Priority Date Filing Date
PL93308551A PL308551A1 (en) 1992-10-28 1993-09-10 Application of bhpa compounds in combination with other nucleosidal inhibitors of reverse transcriptase in treating hiv infections

Country Status (12)

Country Link
EP (1) EP0666744A1 (en)
JP (1) JPH08502745A (en)
KR (1) KR950703958A (en)
AU (1) AU4848293A (en)
CA (1) CA2145545A1 (en)
CZ (1) CZ69695A3 (en)
FI (1) FI952018A0 (en)
HU (1) HUT72050A (en)
MX (1) MX9306031A (en)
NO (1) NO951608L (en)
PL (1) PL308551A1 (en)
WO (1) WO1994009781A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW406075B (en) * 1994-12-13 2000-09-21 Upjohn Co Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
CA2440438C (en) 2001-03-09 2011-05-03 Ortho-Mcneil Pharmaceutical, Inc. Heterocyclic compounds
PL377087A1 (en) 2002-09-06 2006-01-23 Janssen Pharmaceutica, N.V. Heterocyclic compounds
TW201201813A (en) 2010-03-31 2012-01-16 Arqule Inc Substituted benzo-pyrido-triazolo-diazepine compounds
WO2012061342A2 (en) 2010-11-01 2012-05-10 Arqule, Inc. Substituted benzo-imidazo-pyrido-diazepine compounds

Also Published As

Publication number Publication date
FI952018L (en) 1995-04-27
CA2145545A1 (en) 1994-05-11
MX9306031A (en) 1994-04-29
FI952018A7 (en) 1995-04-27
CZ69695A3 (en) 1995-12-13
HUT72050A (en) 1996-03-28
KR950703958A (en) 1995-11-17
JPH08502745A (en) 1996-03-26
WO1994009781A1 (en) 1994-05-11
NO951608D0 (en) 1995-04-27
AU4848293A (en) 1994-05-24
NO951608L (en) 1995-06-28
FI952018A0 (en) 1995-04-27
HU9501218D0 (en) 1995-06-28
EP0666744A1 (en) 1995-08-16

Similar Documents

Publication Publication Date Title
EP0462800A3 (en) Inhibitors of hiv reverse transcriptase
AU2216292A (en) Inhibitors of hiv reverse transcriptase
IL99843A0 (en) Synergistic combination of hiv reverse transcriptase inhibitors
FI950508L (en) Benzoxazinones as HIV reverse transcriptase inhibitors
ZA896864B (en) Method and composition for the treatment and prevention of viral infections
FI981591A7 (en) HIV protease inhibitors useful in the treatment of AIDS
AU2436792A (en) Quinazoline derivatives as inhibitors of hiv reverse transcriptase
FI953954L (en) HIV reverse transcriptase inhibitors
AU1046895A (en) New quinazolines as inhibitors of hiv reverse transcriptase
EP0643580A4 (en) Combinations of ace inhibitors and diuretics.
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
HUT71401A (en) New quinazolines as inhibitors of hiv reverse transcriptase
AU5871694A (en) Combination for treating hiv infections containing thymosine, interleukin and hiv replication or reverse transcriptase inhibitors
PL308551A1 (en) Application of bhpa compounds in combination with other nucleosidal inhibitors of reverse transcriptase in treating hiv infections
HUT77573A (en) Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors
AU7845191A (en) Inhibitors of HIV reverse transcriptase
GB9308781D0 (en) Inhibitors of hiv reverse transcriptase
EP0717622A4 (en) Methods of treating hiv with azaspiranes
ZA914653B (en) Inhibitors of hiv reverse transcriptase
ZA935724B (en) Benzoxazinones as inhibitors of HIV reverse transcriptase
ZA926708B (en) Inhibitors of hiv reverse transcriptase
AU8497191A (en) Compositions and methods for treating hiv infections
ZA918659B (en) Synergism of hiv reverse transcriptase inhibitors
AU3240493A (en) Compounds and compositions for treating HIV infections
ZA929143B (en) Agents for use in the prophylaxis and therapy of fungal infections.